Table 4.
Incidence of testicular germ cell tumors by census region, USCS Registries, 2013–2016
| Testicular germ cell tumors | Seminoma | Nonseminoma | |||||
|---|---|---|---|---|---|---|---|
| Population | Count | Rate (95% CI)1 | Count | Rate (95% CI)1 | Count | Rate (95% CI)1 | |
| NHW | |||||||
| Northeast | 73,926,005 | 5,198 | 7.60 (7.39–7.81) | 3,045 | 4.45 (4.29–4.61) | 2,100 | 3.09 (2.96–3.23) |
| Midwest | 103,504,180 | 6,761 | 7.03 (6.86–7.21) | 3,870 | 4.04 (3.91–4.17) | 2,841 | 2.95 (2.84–3.06) |
| South | 139,582,823 | 7,689 | 5.97 (5.83–6.11) | 4,332 | 3.36 (3.26–3.46) | 3,299 | 2.57 (2.49–2.66) |
| West | 79,049,162 | 5,393 | 7.15 (6.95–7.34) | 3,109 | 4.11 (3.96–4.26) | 2,243 | 3.00 (2.87–3.13) |
| p-value2 | p<0.01 | p<0.01 | p<0.01 | ||||
| Hispanic | |||||||
| Northeast | 15,595,327 | 708 | 4.05 (3.76–4.37) | 366 | 2.20 (1.97–2.44) | 339 | 1.83 (1.64–2.05) |
| Midwest | 10,573,177 | 564 | 4.79 (4.40–5.22) | 276 | 2.51 (2.21–2.84) | 288 | 2.28 (2.03–2.58) |
| South | 41,879,161 | 2,002 | 4.30 (4.11–4.5) | 936 | 2.08 (1.95–2.23) | 1,062 | 2.20 (2.07–2.34) |
| West | 44,999,136 | 2,708 | 5.38 (5.18–5.6) | 1,271 | 2.71 (2.56–2.87) | 1,433 | 2.65 (2.51–2.80) |
| p-value2 | p<0.01 | p<0.01 | p<0.01 | ||||
| NHB | |||||||
| Northeast | 12,530,550 | 188 | 1.51 (1.30–1.75) | 120 | 0.99 (0.82–1.19) | 67 | 0.51 (0.39–0.65) |
| Midwest | 14,356,704 | 181 | 1.35 (1.16–1.57) | 110 | 0.85 (0.70–1.03) | 71 | 0.50 (0.39–0.64) |
| South | 44,802,533 | 548 | 1.29 (1.19–1.41) | 350 | 0.85 (0.76–0.95) | 191 | 0.43 (0.37–0.49) |
| West | 7,785,827 | 119 | 1.48 (1.22–1.79) | 63 | 0.85 (0.65–1.09) | 56 | 0.64 (0.48–0.84) |
| p-value2 | p=0.28 | p=0.56 | p=0.10 | ||||
| A/PI | |||||||
| Northeast | 7,441,532 | 155 | 1.84 (1.56–2.16) | 82 | 0.99 (0.79–1.24) | 71 | 0.82 (0.64–1.04) |
| Midwest | 4,464,157 | 97 | 1.90 (1.53–2.34) | 49 | 1.00 (0.73–1.35) | 46 | 0.86 (0.63–1.17) |
| South | 8,577,925 | 126 | 1.32 (1.1–1.58) | 65 | 0.69 (0.53–0.89) | 61 | 0.63 (0.48–0.82) |
| West | 17,342,731 | 441 | 2.37 (2.15–2.6) | 244 | 1.33 (1.17–1.51) | 197 | 1.04 (0.90–1.19) |
| p-value2 | p<0.01 | p<0.01 | p<0.01 | ||||
| AI/AN | |||||||
| Northeast | 864,515 | 18 | 1.86 (1.09–3.04) | † | † | † | † |
| Midwest | 1,326,177 | 57 | 4.25 (3.19–5.60) | 21 | 1.88 (1.15–2.93) | 36 | 2.37 (1.65–3.37) |
| South | 2,731,767 | 89 | 3.09 (2.47–3.82) | 49 | 1.75 (1.29–2.33) | 40 | 1.34 (0.95–1.85) |
| West | 4,195,866 | 197 | 4.47 (3.86–5.17) | 113 | 2.76 (2.27–3.35) | 83 | 1.68 (1.33–2.11) |
| p-value2 | p<0.01 | †† | †† | ||||
1
Rates are per 100,000 and age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130)
2
Global p-value (calculated from the Wald test)
†
Case counts less than 16 (rate not calculated)
††
p-value not calculated
Abbreviations: A/PI (Asian/Pacific Islander), AI/AN (American Indian/Alaska Native), APC (Annual Percent Change), CI (Confidence Interval), NHW (Non-Hispanic White), NHB (Non-Hispanic Black), US (United States), USCS (United States Cancer Statistics)